Schedule 13G ownership disclosure
Arcturus Therapeutics Holdings Inc
Security class unavailable · CUSIP: 03969T109
Event date: 2020-09-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,584,466
- Percent of class
- 6.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-104394
- Form type
- SC 13G
- Filer
- Arcturus Therapeutics Holdings Inc.
- CIK
- CIK 1768224
- Filed
- Sep 11, 2020
- Reporting period
- Sep 01, 2020
- Description
- Schedule 13G beneficial ownership